Irbesartan
Irbesartan (中文:厄貝沙坦) is an angiotensin receptor blocker.
Pronunciation
Irbesartan 150mg (APROVEL 150mg)
| Generic Name: | Irbesartan |
|---|---|
| Class: | Cardiovascular Drug |
| Subclass: | angiotensin receptor blocker |
| Legal Classification: | P1S1S3 |
Drug Names
| Generic Name 藥物化學名稱 | HA Code 藥物代碼 | Legal Classification法律藥物分類 | Brand Name 藥名 |
|---|---|---|---|
| Irbesartan Tablet 150mg | IRBE01 | P1S1S3 | APROVEL TABLET
C0APROVEL TAB 150/12.5MG (irbesartan 150mg + hydrochlorothiazide 12.5mg) C0APROVEL TAB 300/12.5MG (irbesartan 300mg + hydrochlorothiazide 12.5mg) |
| Irbesartan Tablet 300mg | IRBE02 | P1S1S3 |
Mechanism of Action
Irbesartan relaxes and widens your blood vessels. This lowers your blood pressure and makes it easier for your heart to pump blood around your body. It is used to treat high blood pressure and heart failure. It helps to prevent future strokes, heart attacks and diabetic kidney disease. If you have diabetic kidney disease, it helps to protect your kidneys and slows down the disease. It reduces high blood pressure and the amount of protein you lose through your kidneys.
Route of Administration
Irbesartan is given orally as tablets. After a dose the hypotensive effect peaks within 3 to 6 hours and persists for at least 24 hours. The maximum hypotensive effect is achieved within 4 to 6 weeks after starting therapy.
